New rule optimizes analysis of petitions and reinforces security in pesticide regulation
As of January 2, 2025, Anvisa’s Collegiate Board Resolution (RDC) 950/2024 comes into force, establishing complementary requirements to optimize the toxicological evaluation of pesticides formulated from equivalent technical products. The measure aims to make processes more efficient, maintaining scientific rigor and ensuring safety for the population.
Impacts of RDC 950/2024 on the Regulation of Pesticides
The new standard is applicable to products without technological innovations, whose active ingredients have already been previously evaluated. The objective is to reduce bureaucracy and optimize the toxicological classification, without compromising the safety of the products. To this end, Anvisa regulates the Optimized Reading Tool in the Pesticide Registry (Flora), which since 2019 has been used on an optional basis.
How the Flora tool streamlines toxicological assessment
Flora was developed to structure and systematize key information already present in toxicological dossiers, allowing for a more agile and reliable analysis. The tool facilitates the identification of critical points, provides the final classification of the product and indicates hazard phrases and pictograms according to the standards of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS).
Guidelines for Companies and Adaptation Deadlines
To ensure the correct classification of products, Anvisa published a Technical Note with specific guidelines. Registering companies must submit the Declaration of Constitution and Pesticide Hazard Information (DCIPA) along with the Flora form for all processes, including those already filed. Petitions submitted before the rule came into force have until January 2, 2026 to adapt.
It is worth mentioning that the submission of these requirements does not replace the presentation of the other documents required by health regulations. In addition, Anvisa may carry out technical visits to verify the information provided and, if it identifies inconsistencies, review decisions adopted in the new analysis procedure.
How QR Group Helps with Regulatory Compliance
QR Group is a specialist in health regulation and offers specialized advice to companies that need to ensure compliance with Anvisa. With a highly qualified team, the company assists in the process of petitioning and submitting regulatory documentation, ensuring that foreign and domestic manufacturers comply with all requirements in an agile and safe manner.
If your company needs support to adapt to RDC 950/2024 and optimize product regulation with Anvisa, contact QR Group and count on our expertise to ensure compliance and security in the Brazilian market.
Source: ANVISA
